Cargando…

1511. Effect of Discharge Antibiotic Route on Clinical Outcomes in Children with Methicillin-Resistant Staphylococcus aureus (MRSA) Osteomyelitis with Bacteremia

BACKGROUND: Children with osteomyelitis transitioned to oral step-down therapy experience similar outcomes to those treated with outpatient parenteral antibiotic therapy (OPAT). Compared with OPAT, oral therapy has lower costs and avoids catheter complications. However, few studies have specifically...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olson, Jared, Hamdy, Rana F, Hsu, Alice J, Tamma, Pranita, Gerber, Jeffrey, Dona, Daniele, Hersh, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809963/ http://dx.doi.org/10.1093/ofid/ofz360.1375

Ejemplares similares

Staphylococcus aureus Bacteremia in Children: The Effect of Methicillin Resistance
por: Hamdy, Rana F, et al.
Publicado: (2017)

The Role of Negative Methicillin-Resistant Staphylococcus aureus Nasal Surveillance Swabs in Predicting the Need for Empiric Vancomycin Therapy
por: Chotiprasitsakul, Darunee, et al.
Publicado: (2017)

195. Duration of Therapy for Streptococcal Bacteremia
por: Boulos, John M, et al.
Publicado: (2021)

2253. Comparison of Outcomes Between Patients with and without Cystic Fibrosis Treated with Ceftolozane–Tazobactam for Pseudomonas aeruginosa Infections
por: Trisler, Michael J, et al.
Publicado: (2019)

716 Risk Factors for Resistance to Beta-lactam/Beta-lactamase Inhibitors and Carbapenems in Bacteroides spp. Bacteremia
por: Smith, Janessa, et al.
Publicado: (2014)

Successful Treatment of Persistent Stenotrophomonas maltophilia Bacteremia With Cefiderocol in an Infant
por: Hsu, Alice J, et al.
Publicado: (2023)

Treatment of Staphylococcus aureus Bacteremia in Children: Is Intravenous Therapy Always Needed?
por: Dona, Daniele, et al.
Publicado: (2017)

52. Development and Implementation of a Short Duration of Antibiotic Therapy Algorithm for Uncomplicated Gram-Negative Bacteremia
por: Bae, Esther Y, et al.
Publicado: (2020)

Navigating treatment approaches for presumed ESBL-producing infections
por: Tamma, Pranita D, et al.
Publicado: (2021)

The Impact of Mental Health on Antibiotic Prescribing
por: Keller, Sara C., et al.
Publicado: (2022)

PRO: Testing for ESBL production is necessary for ceftriaxone-non-susceptible Enterobacterales: perfect should not be the enemy of progress
por: Tamma, Pranita D, et al.
Publicado: (2021)

711. Molecular Epidemiology of Daptomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia
por: Sundaram, Ayesha, et al.
Publicado: (2018)

Bilateral Endogenous Bacterial Endophthalmitis Secondary to Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia
por: Darland, Hannah, et al.
Publicado: (2022)

Comparing the Outcomes of Adults with Enterobacteriaceae Bacteremia Receiving Short-Course vs Prolonged-Course Antibiotic Therapy
por: Chotiprasitsakul, Darunee, et al.
Publicado: (2017)

Hemipelvic osteomyelitis in a hemodialysis patient associated with methicillin-resistant Staphylococcus aureus bacteremia
por: Patzkowski, Jeanne C, et al.
Publicado: (2008)

1881. The Agency for Healthcare Research and Quality (AHRQ) Safety Program for Improving Antibiotic Use: Results From a National Antibiotic Stewardship Intervention of 402 United States (US) Hospitals
por: Tamma, Pranita, et al.
Publicado: (2019)

Combination of phage therapy and cefiderocol to successfully treat Pseudomonas aeruginosa cranial osteomyelitis
por: Simner, Patricia J., et al.
Publicado: (2022)

A Mini-Review on Ceftaroline in Bacteremia Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Infections
por: Lounsbury, Nicole, et al.
Publicado: (2019)

An Update on Treatment Options for Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: A Systematic Review
por: Mahjabeen, Fatema, et al.
Publicado: (2022)

Attributable mortality in critically ill patients with bacteremia involving methicillin susceptible (MSSA) and methicillin resistant Staphylococcus aureus (MRSA)
por: Blot, S, et al.
Publicado: (2001)

Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections
por: Shields, Ryan K, et al.
Publicado: (2023)

1804. Impact of Susceptibility Testing Method on Antibiotic Selection for Methicillin-Resistant Staphylococcus Aureus (MRSA) Bacteremia
por: Bhatt, Mahesh, et al.
Publicado: (2018)

Hospital-Related Lineage of USA300 Methicillin-Resistant Staphylococcus aureus (MRSA) to Cause Bacteremia in Iran
por: Navidinia, Masoumeh, et al.
Publicado: (2023)

Impact of PBP2a Assay on Antibiotic Therapy of Patients with Non-Blood, Non-Urine Staphylococcus aureus Infections
por: Shulder, Stephanie, et al.
Publicado: (2017)

2310. Reasons Pediatric Providers Obtain Endotracheal Aspirate Cultures and How Results Inform Patient Management
por: Sick-Samuels, Anna, et al.
Publicado: (2018)

Cefepime Therapy for Cefepime-Susceptible Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bacteremia
por: Wang, Ruibin, et al.
Publicado: (2016)

1588. Clinical Prediction Tool for Extended-Spectrum Β Lactamase-Producing Enterobacteriaceae as the Etiology of Bacteremia in Solid Organ Transplant Recipients
por: Wang, Rebecca, et al.
Publicado: (2018)

Comparative Effectiveness of Antibiotic Treatment Duration in Children With Pyelonephritis
por: Fox, Miriam T., et al.
Publicado: (2020)

282. Epidemiological Evaluation of Methicillin-Resistant Staphylococcus aureus (MRSA) and Methicillin-Susceptible Staphylococcus aureus (MSSA) Bacteremia: A Comprehensive Cancer Center’s 10-Year Experience
por: Ford, Charles R, et al.
Publicado: (2020)

38. Predicting stenotrophomonas Maltophilia bloodstream Infections (BSI) in the Hematologic Malignancy Population
por: Karaba, Sara M, et al.
Publicado: (2020)

Survey of infectious diseases providers reveals variability in duration of antibiotic therapy for the treatment of Gram-negative bloodstream infections
por: Thaden, Joshua T., et al.
Publicado: (2022)

A framework for implementing antibiotic stewardship in ambulatory care: Lessons learned from the Agency for Healthcare Research and Quality Safety Program for Improving Antibiotic Use
por: Keller, Sara C., et al.
Publicado: (2022)

Genome Sequences of Sequence Type 45 (ST45) Persistent Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia Strain 300-169 and ST45 Resolving MRSA Bacteremia Strain 301-188
por: Hernandez, David, et al.
Publicado: (2014)

371 Outcomes of Enterobacter bloodstream infection in hospitalized children
por: Larru, Beatriz, et al.
Publicado: (2014)

Daptomycin susceptibility of methicillin resistant Staphylococcus aureus (MRSA)
por: Kaur, Rajneet, et al.
Publicado: (2012)

Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Choo, Eun Ju, et al.
Publicado: (2016)

Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments
por: McCreary, Erin K, et al.
Publicado: (2019)

1624. Real World Experience with Daptomycin (DAP) and Ceftaroline (CPT) Combination Therapy for Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia
por: Zidaru, Andrei, et al.
Publicado: (2020)

Trends in pediatric community-onset Staphylococcus aureus antibiotic susceptibilities over a five-year period in a multihospital health system
por: Prochaska, Erica C., et al.
Publicado: (2023)

Methicillin-sensitive Staph. aureus (MSSA) and methicillin-resistant Staph. aureus (MRSA) bacteraemia decline simulaneously
por: Coello, R, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_arahe27jccqikqbtbbrgv6ltm6